# A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Years With Recalcitrant Tinea Cruris and Corporis

> **NCT07312604** · NA · RECRUITING · sponsor: **Abeer Mohamed Abdelaziz Elkholy** · enrollment: 50 (estimated)

## Conditions studied

- Tinea Corporis
- Tinea Cruris

## Interventions

- **BIOLOGICAL:** Intra-Lesional MMR Immunotherapy

## Key facts

- **NCT ID:** NCT07312604
- **Lead sponsor:** Abeer Mohamed Abdelaziz Elkholy
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-09
- **Primary completion:** 2026-03-09
- **Final completion:** 2026-03-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07312604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07312604, "A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Years With Recalcitrant Tinea Cruris and Corporis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07312604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*